Related Experiment Video
Updated: Jun 7, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Evaluation of the functional parameters in scleroderma cases with pulmonary involvement
Zeynep Celebi Sözener1, Gülseren Karabıyıkoğlu, Nurşen Düzgün
1Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey. zeynepsozener@gmail.com
Early detection of pulmonary involvement in scleroderma is crucial. Diffusing capacity for carbon monoxide (DLCO%) is the earliest indicator, and various tests aid in monitoring patients, even those without symptoms.
Area of Science:
- Pulmonary Medicine
- Rheumatology
- Diagnostic Imaging
Background:
- Scleroderma often involves the lungs, leading to significant morbidity.
- Early identification of pulmonary involvement is critical for timely intervention and improved patient outcomes.
Purpose of the Study:
- To assess the relationship between functional changes in scleroderma patients with pulmonary involvement and diagnostic tests.
- To identify diagnostic tools for the early detection of lung complications in scleroderma.
Main Methods:
- Prospective study of 33 scleroderma patients with pulmonary involvement.
- Utilized pulmonary function tests, echocardiography, arterial blood gases, 6-minute walk tests, and high-resolution computed tomography (HRCT).
- Assessed functional status using MRC dyspnea scores, NYHA (WHO) classification, and St. George's Respiratory Questionnaire (SGRQ).
Main Results:
- Diffusing capacity for carbon monoxide (DLCO%) emerged as the earliest deteriorated parameter.
- The FVC%/DLCO% ratio showed low sensitivity for detecting pulmonary arterial hypertension noninvasively.
- SGRQ scores correlated significantly with all functional parameters in scleroderma follow-up.
Conclusions:
- Scleroderma patients require regular evaluation for pulmonary involvement, irrespective of symptoms.
- Pulmonary function tests, echocardiography, HRCT, and 6-minute walk tests are valuable for diagnosis and monitoring.
- NYHA (WHO) classification, MRC, Borg dyspnea scores, and SGRQ are helpful for early diagnosis and functional assessment.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
